 CNS Pharmaceuticals, Inc. NASDAQ: CNSP CNS or the Company, a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announced today it has completed shipping its Active Pharma Ingredient API to both Maryland based Pharmaceutics International, Inc., Pii and Italian BSP Pharmaceuticals S.p.A., BSP, respectively, for the production of Berubicin. 